Overview

Gender

male

Fred Turner is the Chief Executive Officer and Founder of Curative, a COVID-19 testing company scaling a self-collected oral fluid swab for the detection of SARS-CoV-2. A British scientist from West Yorkshire, Turner attended the University of Oxford. Mr. Turner was named one of the top 100 practicing scientists in the UK by the Science Council 2013. Turner was included in Forbes “30 Under 30” list and ranked first in the European Union Contest for Young Scientist.

Turner previously founded and led a 16z and YC-backed diagnostics (Dx) startup that built a CLIA lab for validating and launching an STD testing product in Menlo Park, California. This product was administered to over 10,000 patients in medical centers across 5 United States. Other previous roles include Chief Executive Officer at Shield Bio, focusing on solving the issue of antibiotic resistance related to cancer.